Indeed, SHIP1 had an antagonistic effect on the downstream signaling of the B cell receptor, as demonstrated by the reduced activation of the AKT signaling cascade in B-ALL cells with high SHIP1 expression [11]. The gene discussed is INPP5D; the disease is precursor B-cell acute lymphoblastic leukemia.